We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novozymes Biopharma to Present on Creating Market Opportunities Through Drug Half-Life Extension at 2011 BIO Business Forum

News   Jun 24, 2011

 
Novozymes Biopharma to Present on Creating Market Opportunities Through Drug Half-Life Extension at 2011 BIO Business Forum
 
 
 

RELATED ARTICLES

Precise Measuring Tool for Optimal Antibody Effectiveness

News

Using DNA origami scientists have been able to demonstrate the most accurate distance between densely packed antigens in order to get the strongest bond to antibodies in the immune system.

READ MORE

Antimicrobial Peptides Freeze Cytoplasmic Motion, Render Bacteria Susceptible to Attack

News

A previously unknown mechanism has been revealed for LL-37 and similar peptides, which are being tested in early-stage clinical trials for treating infections resistant to classical antibiotics.

READ MORE

Immunotherapy Opportunities Lie in Glioma Molecular Landscape

News

A slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which gives the immune system a boost in fighting cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE